Biotech · Private company
MediLink Therapeutics (Suzhou) Co., Ltd.
Track this companyFree. Adds MediLink Therapeutics (Suzhou) Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials88 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- AtezolizumabPhase 2 · Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- intravenous (IV) infusionPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- YL201Phase 2 · Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- YL201Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL201 and atezolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL242Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL242; 5-FU; LVPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL242; PembrolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL242; Pembrolizumab; 5-FUPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- 5-FU with leucovorinPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- YL202Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- YL211Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- YL211 + Pembro or Pembro+ Pemetrexed + (Carboplatin or Cisplatin)Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- YL211+PembrolizumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- YL217Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Mar 31, 2026ClinicalTrials.gov NCT07407933 · fetched Nov 12, 2026
- A Study of YL242 in Subjects With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Sep 22, 2025ClinicalTrials.gov NCT07197827 · fetched Nov 12, 2026
- A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)PHASE1_PHASE2 · RECRUITING · started Sep 22, 2025ClinicalTrials.gov NCT07111520 · fetched Nov 12, 2026
- A First-in-Human Study of YL217 in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started Jul 2, 2025ClinicalTrials.gov NCT06859762 · fetched Nov 12, 2026
- A Clinical Study of YL205 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Jun 4, 2024ClinicalTrials.gov NCT06459973 · fetched Nov 12, 2026
- Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid TumorsPHASE1 · RECRUITING · started May 1, 2024ClinicalTrials.gov NCT06384352 · fetched Nov 12, 2026
- A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 20, 2022ClinicalTrials.gov NCT05653752 · fetched Nov 12, 2026
- A Study of YL201 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 25, 2022ClinicalTrials.gov NCT05434234 · fetched Nov 12, 2026